Artielle ImmunoTherapeutics Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Artielle ImmunoTherapeutics General Information
Description
Operator of a biopharmaceutical company intended to obtain biological drugs to treat degenerative diseases. The company's biological platform drugs target the CD74 receptor on monocytes and block the action of macrophage migration inhibitory factor, enabling the healthcare industry to treat neuroinflammatory diseases including multiple sclerosis, optic neuritis, methamphetamine addiction, and stroke.
Contact Information
Website
www.artielle.comCorporate Office
- Care Of Reference Capital Management Limited Liability Company
- 7320 South West Hunziker Road, Suite 104
- Tigard, OR 97223
- United States
Corporate Office
- Care Of Reference Capital Management Limited Liability Company
- 7320 South West Hunziker Road, Suite 104
- Tigard, OR 97223
- United States
Artielle ImmunoTherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Feb-2021 | Completed | Clinical Trials - Phase 1 | |||
| 1. Later Stage VC (Series A) | 07-Sep-2010 | Completed | Clinical Trials - Phase 1 |
Artielle ImmunoTherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Artielle ImmunoTherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Artielle ImmunoTherapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Northwest Technology Ventures | Venture Capital | Minority | ||
| Sanderling Ventures | Venture Capital | Minority |
Artielle ImmunoTherapeutics FAQs
-
When was Artielle ImmunoTherapeutics founded?
Artielle ImmunoTherapeutics was founded in 2004.
-
Where is Artielle ImmunoTherapeutics headquartered?
Artielle ImmunoTherapeutics is headquartered in Tigard, OR.
-
What is the size of Artielle ImmunoTherapeutics?
Artielle ImmunoTherapeutics has 6 total employees.
-
What industry is Artielle ImmunoTherapeutics in?
Artielle ImmunoTherapeutics’s primary industry is Drug Discovery.
-
Is Artielle ImmunoTherapeutics a private or public company?
Artielle ImmunoTherapeutics is a Private company.
-
What is Artielle ImmunoTherapeutics’s current revenue?
The current revenue for Artielle ImmunoTherapeutics is .
-
How much funding has Artielle ImmunoTherapeutics raised over time?
Artielle ImmunoTherapeutics has raised $16.4M.
-
Who are Artielle ImmunoTherapeutics’s investors?
Northwest Technology Ventures and Sanderling Ventures have invested in Artielle ImmunoTherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
